Human samples
The current study includes two distinct SjD cohorts: an observational disease–control cohort (SjD–sicca) and the TRACTISS randomized clinical trial, comparing rituximab versus placebo treatment in patients with SjD (Supplementary…
Lactate signalling leads to aggregation of immune-inflammatory hotspots and SLC5A12 blockade promotes their resolution
